CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 123 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $649,000 | +29.0% | 51,348 | +0.3% | 0.00% | – |
| Q3 2020 | $503,000 | +269.9% | 51,207 | +351.2% | 0.00% | – |
| Q2 2019 | $136,000 | +9.7% | 11,349 | +10.6% | 0.00% | – |
| Q1 2019 | $124,000 | -12.7% | 10,260 | -9.1% | 0.00% | – |
| Q4 2018 | $142,000 | -77.0% | 11,288 | -72.9% | 0.00% | -100.0% |
| Q3 2018 | $618,000 | -56.0% | 41,668 | -50.1% | 0.00% | 0.0% |
| Q2 2018 | $1,405,000 | -29.2% | 83,490 | -3.7% | 0.00% | -50.0% |
| Q1 2018 | $1,985,000 | +168.6% | 86,671 | +203.4% | 0.00% | +100.0% |
| Q4 2017 | $739,000 | +370.7% | 28,563 | +169.1% | 0.00% | – |
| Q3 2017 | $157,000 | – | 10,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |